regulatory_update

Frankfurt/Main – September 08, 2026 -- Germany's fertilizer industry association IVA has warned that a planned flat-rate hectare premium for EU fertilizer aid will not drive the early purchasing decisions farms need to secure supply for spring 2026.

IVA says hectare premium misses fertilizer action plan's core goal

The Industrieverband Agrar e.V. (IVA) criticized the German Federal Ministry of Agriculture, Food and Home Affairs' plan to disburse EU fertilizer subsidies as a flat hectare payment, arguing the approach undermines the original intent of the European Fertiliser Action Plan to support farmers specifically in purchasing fertilizer. IVA Managing Director Frank Gemmer said the payout structure lacks the steering effect needed to encourage timely buying, and called instead for direct financial support tied to fertilizer purchases.

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark lawsuit centered on Aura's NeuroRush® ingredient and FutureCeuticals' whole coffee fruit extract sold as CognatiQ® and NeuroFactor®.

Settlement terminates Aura's NeuroRush ingredient and validates FutureCeuticals' IP

The resolution ends production of NeuroRush® and confirms the enforceability of FutureCeuticals' intellectual property covering its whole coffee fruit extract. J. Randal Wexler, Vice President and Chief Legal Officer at FutureCeuticals, said Aura's acknowledgment of the IP's validity reinforces its market value and supports continued investment in clinical research.

Momence, Ill. – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have resolved a patent and trademark lawsuit centered on Aura's NeuroRush ingredient, with Aura agreeing to discontinue NeuroRush and transition to FutureCeuticals' CognatiQ whole coffee fruit extract.

Legal dispute ends with Aura exiting NeuroRush ingredient line

The lawsuit involved FutureCeuticals' cognitive health intellectual property tied to its whole coffee fruit extract, sold under the tradenames CognatiQ and NeuroFactor. J. Randal Wexler, FutureCeuticals' Vice President & General Counsel, said Aura's acknowledgment of the IP's validity reinforces its market strength. Wexler noted the company's IP enforcement protects continued investment in clinical research while safeguarding customer and partner interests.

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark dispute over Aura's cognitive-health ingredient "NeuroRush," ending the product and replacing it with a new distribution partnership for FutureCeuticals' whole coffee cherry extract, sold as "CognatiQ" and "NeuroFactor."

Settlement terminates NeuroRush, validates FutureCeuticals' IP portfolio

The resolution confirms the validity of FutureCeuticals' intellectual property in the cognitive health ingredient category, according to J. Randal Wexler, the company's Vice President and General Counsel. Aura's NeuroRush ingredient will be discontinued as part of the agreement.

Dallas – September 08, 2026 -- Cango Inc. (NYSE: CANG) has regained compliance with the New York Stock Exchange's minimum share price requirement, the company said, closing a listing-standards issue that began in March.

NYSE confirms Cango cleared the $1.00 threshold as of August 31, 2026

In a letter dated September 1, 2026, the NYSE notified Cango that its average closing share price over the 30 trading days ended August 31, 2026 exceeded the exchange's US$1.00 minimum under Section 802.01C of the NYSE Listed Company Manual. The exchange confirmed the matter is now closed.

Company had received a deficiency notice on March 10, 2026

The NYSE had flagged Cango after its Class A ordinary shares' 30-trading-day average closing price fell below $1.00, triggering a formal compliance notification.

Berlin – September 07, 2026 -- Hans-Werner Borries, deputy chairman of Germany's Federal Association for the Protection of Critical Infrastructure (BSKI), said security measures at critical infrastructure sites across Germany are currently inadequate to counter a new wave of suspected sabotage attacks on the power grid.

Borries Says Suspected Foreign-State Sabotage Marks Start of Pre-Hybrid Warfare Phase

Speaking on rbb24 Inforadio Thursday, Borries said that as long as even initial suspicion of foreign state-directed sabotage persists, infrastructure operators are operating in a phase of pre-hybrid warfare. He said protecting infrastructure assets is no longer straightforward, forcing companies to reassess whether current investment levels are sufficient.

Tysons Corner, Virginia – September 07, 2026 -- Cellebrite DI Ltd. (Nasdaq: CLBT) said its cloud-based digital evidence management platform, Guardian, has completed an assessment under Australia's Infosec Registered Assessors Program (IRAP) at the PROTECTED classification level, clearing a key hurdle for adoption by Australian law enforcement, defense and national security agencies.

CyberCX, an ASD-approved assessor, conducted the independent review

The evaluation was carried out by CyberCX, an IRAP assessment body accredited by the Australian Signals Directorate (ASD). The certification gives Australian agencies documented, independent evidence that Guardian can handle sensitive digital evidence workloads in the cloud without compromising security.

Dubai, UAE – September 07, 2026 -- XTransfer has secured in-principle approval for a Retail Payment Services Licence from the Central Bank of the UAE, a move that will let the B2B cross-border payment platform serve mainland UAE clients once pre-issuance conditions are met.

Regulator clears path for mainland UAE trade payments

The licence extends XTransfer's regulated payment services into the UAE, positioning the company to support businesses engaged in international trade with compliant, secure cross-border transaction tools once formal issuance is complete.

UAE approval anchors China-Middle East-Africa trade corridor

The UAE serves as a major regional trade and re-export hub connecting Chinese commerce with Africa and other emerging markets. XTransfer said the licence strengthens its capacity to support trade flows between China, the Middle East and Africa with more accessible cross-border payment infrastructure.

Nanjing – September 07, 2026 -- Scage Future (Nasdaq: SCAG) has fallen below two separate Nasdaq minimum listing thresholds, receiving deficiency notices tied to both its total market value of listed securities and its market value of publicly held shares.

Nasdaq flags dual shortfalls in 30-day trading review

The Listing Qualifications Department of The Nasdaq Stock Market sent two notification letters dated August 27, 2026. Based on the 30 consecutive business days from July 16 to August 26, 2026, Scage's Market Value of Listed Securities (MVLS) fell short of the required US$50,000,000 minimum under Rule 5450(b)(2)(A). Nasdaq also noted the company fails the alternative Total Assets and Total Revenue standard under Rule 5450(b)(3)(A). A second letter cited the company's Market Value of Publicly Held Shares (MVPHS) falling below the required US$15,000,000 minimum under Rule 5450(b)(2&3)(C) over the same period.

Austin, Texas – – September 07, 2026 -- The U.S. Bankruptcy Court for the Southern District of Texas has confirmed TPx's Plan of Reorganization, clearing the managed services provider to emerge from Chapter 11 with a lighter debt load and fresh capital access.

Court confirmation sets up new ownership structure for TPx

Under the confirmed Plan, a group of investors comprising TPx's existing lenders and its equity sponsor will become the company's new owners once regulatory approvals and customary closing conditions are satisfied. The group will also provide new financing, leaving TPx well capitalized upon emergence.